Recurrent Breast Cancer Treated Successfully with Mitomycin-C and Vinblastine after Failure of Both Doxorubicin-containing Regimen and Paclitaxel : A Case Report

スポンサーリンク

概要

• 論文の詳細を見る
• 1996-03-01

著者

• ITOH Kuniaki

  Division of Oncology and Hematology, National Cancer Center Hospital East

• OHTSU Tomoko

  Amgen Limited

• OHTSU Tomoko

  Division of Oncology/Hematology, Department of Medicine, National Cancer Center Hospital East

• IGARASHI Tadahiko

  Division of Oncology/Hematology, Department of Medicine, National Cancer Center Hospital East

• SASAKI Yasutsuna

  Division of Oncology/Hematology, Department of Medicine, National Cancer Center Hospital East

• SEKINE Ikuo

  Division of Internal Medicine and Thoracic Oncology, National Cancer Center Hospital

• Itoh K

  Division Of Oncology And Hematology National Cancer Center Hospital East

• Igarashi T

  Division Of Oncology And Hematology National Cancer Center Hospital East

• Igarashi Tadahiko

  神戸大学 医学研究科腫瘍内科学

• Igarashi Tadahiko

  国立がんセンター東病院

• Igarashi Tadahiko

  Division Of Hematology And Oncology National Cancer Center Hospital East

• Ichimura Koichi

  Department Of Hematology And Rheumatology Tohoku University Graduate School Of Medicine

• Ishizawa Kenichi

  東北大学 血液･免疫病学分野

• Ishizawa Kenichi

  国立がんセンター東病院

• SASAKI Yasutsuna

  National Cancer Center Hospital East

• WAKITA Hisashi

  Division of Hematology and Oncology, Japanese Red Cross Narita Hospital

• Itoh Kuniaki

  Division Of Oncology And Hematology National Cancer Center Hospital East

• FUJII HIROBUMI

  Division of Oncology/Hematology, National Cancer Center Hospital East

• ABE KAORU

  Division of Oncology/Hematology, National Cancer Center Hospital East

• Fujii H

  Division Of Oncology And Hematology National Cancer Center Hospital East

• Sasaki Yasutsuna

  Division Of Oncology And Hematology National Cancer Center Hospital East

• Ichimura Koichi

  Department Of Pathology And Molecular Diagnostics Aichi Cancer Center

• Fujii Hideji

  Research Laboratories Pharmaceuticals Group Nippon Kayaku Co. Ltd.

• Wakita Hisashi

  Division Of Hematology And Oncology National Cancer Center Hospital East

• Wakita Hisashi

  Division Of Hematology And Oncology Japanese Red Cross Narita Hospital

• Ohtsu Tomoko

  Division Of Oncology/hematology National Cancer Center Hospital East

• Sekine Ikuo

  Department Of Internal Medicine National Cancer Center Hospital

• Sekine Ikuo

  Division Of Internal Medicine And Thoracic Oncology National Cancer Center Hospital

• Itoh Kuniaki

  Division Of Hematology Department Of Internal Medicine Hyogo College Of Medicine

• Abe Kaoru

  Division Of Oncology/hematology National Cancer Center Hospital East

• Sasaki Yasutsuna

  Division Of Hematology And Oncology National Cancer Center Hospital East

• Takahashi Isao

  Second Department Of Internal Medicine Okayama University Medical School

• Itoh Kuniaki

  Division of Hematology and Oncology, National Cancer Center Hospital East

• Ohtsu Tomoko

  Division of Hematology and Oncology, National Cancer Center Hospital East

関連論文

• Extreme eosinophilia caused by interleukin-5-producing disseminated colon cancer
• Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma
• Clonal Analysis of Bilateral, Recurrent, or Systemically Multifocal Ocular Adnexal Lymphoma
• 日本人におけるGSTT1及びGSTM1の遺伝子多型の同定及びハプロタイプ構造の解析
• Genetic Variations of VDR/NR1I1 Encoding Vitamin D Receptor in a Japanese Population
• Different Kinetics of WT1 and PML-RARα Gene Expression Levels during Remission Induction Therapy with All-trans Retinoic Acid Alone in Acute Promyelocytic Leukemia
• Monitoring Minimal Residual Disease in Leukemia Using Real-time Quantitative Polymerase Chain Reaction for Wilms Tumor Gene (WT1)
• Lethal Adenovirus Infection in a Patient Who Had Undergone Nonmyeloblative Stem Cell Transplantation
• Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
• Phase 1 trial of denosumab safety, pharmacokinetics, and pharmacodynamics in Japanese women with breast cancer-related bone metastases
• Phase I Study of Intravenous PSC-833 and Doxorubicin: Reversal of Multidrug Resistance
• A literature review of molecular markers predictive of clinical response to cytotoxic chemotherapy in patients with breast cancer
• Severe hypogammaglobulinemia persisting for 6 years after treatment with rituximab combined chemotherapy due to arrest of B lymphocyte differentiation together with alteration of T lymphocyte homeostasis
• Acquired hemophilia A with sigmoid colon cancer : successful treatment with rituximab followed by sigmoidectomy
• A retrospective analysis of bortezomib therapy for Japanese patients with relapsed or refractory multiple myeloma : β2-microglobulin associated with time to progression
• Dose Modification of Imatinib by Monitoring the Level of BCR-ABL Transcript in Chronic Myelogenous Leukemia
• Increased Expression of Insulin-Like Growth Factor I is Associated with Ara-C Resistance in Leukemia
• Imatinib Mesylate in Conjunction with Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Philadelphia Chromosome Positive Leukemias : Report of 4 Cases
• Detection of Clone-Specific Immunoglobulin Heavy Chain Genes in the Bone Marrow of B-cell-Lineage Lymphoma after Treatment
• High Expression of YB-1 Gene in Erythroid Cells in Patients with Refractory Anemia
• Separation of antileukemic effects from graft-versus-host disease in MHC-haploidentical murine bone marrow transplantation : participation of host immune cells
• Phase I study of radioimmunotherapy with an anti-CD20 murine radioimmunoconjugate (^Y-ibritumomab tiuxetan) in relapsed or refractory indolent B-cell lymphoma
• Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
• Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
• Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy
• Phase III study to evaluate the use of high-dose chemotherapy as consolidation of treatment for high-risk postoperative breast cancer : Japan Clinical Oncology Group study, JCOG 9208
• Case-control study of leukemia and diagnostic radiation exposure
• Phase III Study of Ranimustine, Cyclophosphamide, Vincristine, Melphalan, and Prednisolone (MCNU-COP/MP) versus Modified COP/MP in Multiple Myeloma : A Japan Clinical Oncology Group Study, JCOG 9301
• Infectious complications during remission induction therapy in 577 patients with acute myeloid leukemia in the Japan Adult Leukemia Study Group studies between 1987 and 1991
• Randomized phase II study of concurrent and sequential rituximab and CHOP chemotherapy in untreated indolent B-cell lymphoma
• Phenotypic analysis of peripheral T/NK cell lymphoma : Study of 408 Japanese cases with special reference to their anatomical sites
• Correlation Between Histological Evaluation and PCR-based Clonality Analysis of Gastric MALT Lymphomas Treated by Eradication of Helicobacter pylori
• Follicular lymphoma frequently originates in the salivary gland
• p27^ is Detected on Most Gastric MALT Lymphomas, but not Large Cell Lymphomas
• Morphological spectrum of cyclin D1-positive mantle cell lymphoma : Study of 168 cases
• Pregnancy-Associated Cytotoxic Lymphoma: A Report of 4 Cases
• A phase II, open-label, sequential-cohort, dose-escalation study of romiplostim in Japanese patients with chronic immune thrombocytopenic purpura
• Population pharmacokinetics of docetaxel in patients with hepatic dysfunction treated in an oncology practice
• Pharmacokinetics and pharmacodynamics of protein-unbound docetaxel in cancer patients
• Extragonadal germ cell tumors in Japan
• Treatable Subsets in Cancer of Unknown Primary Origin
• Toxicity and efficacy of ifosfamide, carboplatin and etoposide (modified ICE) as a salvage chemotherapy in Japanese patients with relapsed or refractory aggressive non-Hodgkin's lymphoma
• Recurrent Breast Cancer Treated Successfully with Mitomycin-C and Vinblastine after Failure of Both Doxorubicin-containing Regimen and Paclitaxel : A Case Report
• A Limited Sampling Model for Estimating Pharmacokinetics of CPT-11 and Its Metabolite SN-38
• Pharmacological Correlation between Total Drug Concentration and Lactones of CPT-11 and SN-38 in Patients Treated with CPT-11
• Atypical Lymphoplasmacytic and Immunoblastic Proliferation of Autoimmune Disease : Clinicopathologic and Immunohistochemical Study of 9 Cases
• Sensitive immunohistochemical detection of WT1 protein in tumors with anti-WT1 antibody against WT1 235 peptide
• Safety and efficacy of rasburicase (SR29142) in a Japanese phase II study
• A Randomized Controlled Trial Investigating the Survival Benefit of Dose-Intensified Multidrug Combination Chemotherapy (LSG9) for Intermediate- or High-Grade Non-Hodgkin's Lymphoma : Japan Clinical Oncology Group Study 9002
• Re-Treatment of Relapsed Indolent B-Cell Lymphoma With Rituximab
• Fludarabine- and Cyclophosphamide-Based Nonmyelobalative Conditioning Regimen for Transplantation of Chronic Granulomatous Disease : Possible Correlation with Prolonged Pure Red Cell Aplasia
• Microbial Serine Carboxypeptidase Inhibitors : Comparative Analysis of Actions on Homologous Enzymes Derived from Man, Yeast and Wheat
• Clinical, biochemical, and cytochemical studies on a Japanese Salla disease case associated with a renal disorder
• Bodyweight change during the first 5 days of chemotherapy as an indicator of cisplatin renal toxicity
• What is the most informative pharmacodynamic model for paclitaxel (T)? : a 3 hour-infusion vs. 24-hour infusion.
• Problems with Registration-Directed Clinical Trials for Lung Cancer in Japan
• Phase I study of cisplatin, vinorelbine, and concurrent thoracic radiotherapy for unresectable stage III non-small cell lung cancer
• Tumor response to chemotherapy : The validity and reproducibility of RECIST guidelines in NSCLC patients
• Association between Smoking and Tumor Progression in Japanese Women with Adenocarcinoma of the Lung
• Mediastinal Germ Cell Tumor Complicated by Visceral Hemangiomatosis
• Microsatellite Instability in Lung Cancer Patients 40 Years of Age or Younger
• Suicide Gene Therapy for Chemically Induced Rat Bladder Tumor Entailing Instillation of Adenoviral Vectors
• Photo-Induced Reactions of Oxime O-Ethers Derived from 3-Acyl-1, 2-dihydrocinnoline- 1, 2-dicarboximides
• Novel Photo-Rearrangement of Oxime Methyl Ethers of 3-Acyl-1, 2dihydrocinnoline-N-phenyl-1, 2-dicarboximides
• Long-term follow-up of patients with unresectable locally advanced non-small cell lung cancer treated with chemoradiotherapy: A retrospective analysis of the data from the Japan Clinical Oncology Group trials (JCOG0003A)
• Phase I Study of Paclitaxel by Three-hour Infusion : Hypotension Just after Infusion Is One of the Major Dose-limiting Toxicities
• In situ Gene Transfer and Suicide Gene Therapy of Gastric Cancer Induced by N-Ethyl-N'-nitro-N-nitrosoguanidine in Dogs
• Positron Emission Tomography/Computed Tomography after Immunocytochemical and Clonal Diagnosis of Intraocular Lymphoma with Vitrectomy Cell Blocks
• Phase I study of TLR9 agonist PF-3512676 in combination with carboplatin and paclitaxel in patients with advanced non-small-cell lung cancer
• Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma
• Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab
• Serum soluble interleukin-2 receptor level and immunophenotype are prognostic factors for patients with diffuse large B-cell lymphoma
• A Pharmacokinetic and Pharmacodynamic Analysis of CPT-11 and Its Active Metabolite SN-38
• Frequent downregulation or loss of CD79a expression in plasma cell myelomas : Potential clue for diagnosis
• Correlation Between Histological Evaluation and PCR-based Clonality Analysis of Gastric MALT Lymphomas Treated by Eradication of Helicobacter pylori
• Immunoglobulin G4 (IgG4)-Positive or -Negative Ocular Adnexal Benign Lymphoid Lesions in Relation to Systemic Involvement
• Phase I study of the oral mammalian target of rapamycin inhibitor everolimus (RAD001) in Japanese patients with relapsed or refractory non-Hodgkin lymphoma
• Atypical Lymphoplasmacytic and Immunoblastic Proliferation of Autoimmune Disease : Clinicopathologic and Immunohistochemical Study of 9 Cases
• Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma : Japan Clinical Oncology Group study (JCOG 9305)
• Randomized phase II study of concurrent and sequential combinations of rituximab plus CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) chemotherapy in untreated indolent B-cell non-Hodgkin lymphoma : 7-year follow-up results
• Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
• BAFF-R is Expressed on B-cell Lymphomas Depending on their Origin, and its Related to Proliferation Index of Nodal Diffuse Large B-cell Lymphomas
• Review of primary unknown cancer : cases referred to the National Cancer Center Hospital East
• Comparison of Long-Term Clinical Outcomes of CHOP Chemotherapy between Japanese Patients with Nodal Peripheral T-Cell Lymphomas and Those with Diffuse Large B-Cell Lymphoma in the Study Group of the Tohoku Hematology Forum
• Bilateral Conjunctival Lesions in Blastic Plasmacytoid Dendritic Cell Neoplasm
• Clinicopathological Features of Malignant Lymphoma in Japan : The Miyagi Study
• Relevance of monitoring metabolic reduction in patients with relapsed or refractory follicular and mantle cell lymphoma receiving bendamustine : a multicenter study
• Innovator and generic cisplatin formulations : Comparison of renal toxicity
• Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia : a retrospective safety analysis
• Direct antiglobulin test-negative autoimmune hemolytic anemia associated with HLA-haploidentical stem cell transplantation
• Use of mycophenolate mofetil in patients received allogeneic hematopoietic stem cell transplantation in Japan
• Successful treatment with nilotinib after imatinib failure in a CML patient with a four-way Ph chromosome translocation and point mutations in BCR/ABL gene
• Neurotoxins, 1-methy1-4-phenyl-1, 2, 3, 6-tetrahydropyridine, 1, 2, 3, 4, -tetrahydroisoquinoline, N-methyl-tetrahydroisoquinoline and 1-benzyl-tetrahydroisoquinoline, are substrates for rat liver flavin-containing monooxygenase(FMO) expressed in yeast
• Rituximab monotherapy with eight weekly infusions for relapsed or refractory patients with indolent B cell non-Hodgkin lymphoma mostly pretreated with rituximab : A multicenter phase II study
• Local Recurrence as Immunoglobulin G4 (IgG4)-Related Disease 10 Years after Radiotherapy to Ocular Adnexal Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue
• Strategy for bone marrow transplantation in eculizumab-treated paroxysmal nocturnal hemoglobinuria
• Diagnosis of Intestinal Graft-versus-Host Disease and Thrombotic Microangiopathy after Allogeneic Stem Cell Transplantation
• Orbital MALT Lymphoma, Abdominal Hodgkin lymphoma, and Systemic Diffuse Large B-cell Lymphoma Develop Sequentially in One Patient
• Feasibility of unmanipulated haploidentical stem cell transplantation using standard GVHD prophylaxis for HLA-homozygous patients
• Phase II study of cyclophosphamide, doxorubicin, vincristine, prednisolone (CHOP) therapy for newly diagnosed patients with low-and low-intermediate risk, aggressive non-Hodgkin's lymphoma : final results of the Japan Clinical Oncology Group Study, JCOG95

もっと見る 閉じる

スポンサーリンク